APA (7th ed.) Citation

Peluso, M. J., Takahashi, S., Hakim, J., Kelly, J. D., Torres, L., Iyer, N. S., . . . Vallari, A. (2021). SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Science Advances, 7(31), 1. https://doi.org/10.1126/sciadv.abh3409

Chicago Style (17th ed.) Citation

Peluso, Michael J., et al. "SARS-CoV-2 Antibody Magnitude and Detectability Are Driven by Disease Severity, Timing, and Assay." Science Advances 7, no. 31 (2021): 1. https://doi.org/10.1126/sciadv.abh3409.

MLA (9th ed.) Citation

Peluso, Michael J., et al. "SARS-CoV-2 Antibody Magnitude and Detectability Are Driven by Disease Severity, Timing, and Assay." Science Advances, vol. 7, no. 31, 2021, p. 1, https://doi.org/10.1126/sciadv.abh3409.